Blinatumomab

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
 (blih-nuh-TOO-moh-mab)

This page contains brief information about blinatumomab and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Blincyto
FDA Approved
Yes

FDA Approval for Blinatumomab (2017)

FDA Approval for Blinatumomab (2014)

Use in Cancer

Blinatumomab is approved to treat:

Blinatumomab is also being studied in the treatment of other types of cancer.

More About Blinatumomab

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Blinatumomab - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Research Results and Related Resources

FDA Grants Full Approval to Blinatumomab for Acute Lymphoblastic Leukemia

Blinatumomab Extends Survival for Patients with Advanced ALL

Targeted Cancer Therapies

Clinical Trials Accepting Patients

Find Clinical Trials for Blinatumomab - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted: December 22, 2014
  • Updated: July 27, 2017